IBDEI0IH ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18612,0)
 ;;=I65.8^^84^965^15
 ;;^UTILITY(U,$J,358.3,18612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18612,1,3,0)
 ;;=3^Occlusion/Stenosis of Precerebral Arteries NEC
 ;;^UTILITY(U,$J,358.3,18612,1,4,0)
 ;;=4^I65.8
 ;;^UTILITY(U,$J,358.3,18612,2)
 ;;=^5007364
 ;;^UTILITY(U,$J,358.3,18613,0)
 ;;=I70.211^^84^965^8
 ;;^UTILITY(U,$J,358.3,18613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18613,1,3,0)
 ;;=3^Athscl Native Arteries of Right Leg w/ Intrmt Claud
 ;;^UTILITY(U,$J,358.3,18613,1,4,0)
 ;;=4^I70.211
 ;;^UTILITY(U,$J,358.3,18613,2)
 ;;=^5007578
 ;;^UTILITY(U,$J,358.3,18614,0)
 ;;=I70.212^^84^965^7
 ;;^UTILITY(U,$J,358.3,18614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18614,1,3,0)
 ;;=3^Athscl Native Arteries of Left Leg w/ Intrmt Claud
 ;;^UTILITY(U,$J,358.3,18614,1,4,0)
 ;;=4^I70.212
 ;;^UTILITY(U,$J,358.3,18614,2)
 ;;=^5007579
 ;;^UTILITY(U,$J,358.3,18615,0)
 ;;=I70.213^^84^965^6
 ;;^UTILITY(U,$J,358.3,18615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18615,1,3,0)
 ;;=3^Athscl Native Arteries of Bilateral Legs w/ Intrmt Claud
 ;;^UTILITY(U,$J,358.3,18615,1,4,0)
 ;;=4^I70.213
 ;;^UTILITY(U,$J,358.3,18615,2)
 ;;=^5007580
 ;;^UTILITY(U,$J,358.3,18616,0)
 ;;=I71.2^^84^965^20
 ;;^UTILITY(U,$J,358.3,18616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18616,1,3,0)
 ;;=3^Thoracic Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,18616,1,4,0)
 ;;=4^I71.2
 ;;^UTILITY(U,$J,358.3,18616,2)
 ;;=^5007787
 ;;^UTILITY(U,$J,358.3,18617,0)
 ;;=I71.4^^84^965^1
 ;;^UTILITY(U,$J,358.3,18617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18617,1,3,0)
 ;;=3^AAA w/o Rupture
 ;;^UTILITY(U,$J,358.3,18617,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,18617,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,18618,0)
 ;;=I73.9^^84^965^17
 ;;^UTILITY(U,$J,358.3,18618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18618,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,18618,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,18618,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,18619,0)
 ;;=I74.2^^84^965^11
 ;;^UTILITY(U,$J,358.3,18619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18619,1,3,0)
 ;;=3^Embolism/Thrombosis of Upper Extremity Arteries
 ;;^UTILITY(U,$J,358.3,18619,1,4,0)
 ;;=4^I74.2
 ;;^UTILITY(U,$J,358.3,18619,2)
 ;;=^5007801
 ;;^UTILITY(U,$J,358.3,18620,0)
 ;;=I74.3^^84^965^10
 ;;^UTILITY(U,$J,358.3,18620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18620,1,3,0)
 ;;=3^Embolism/Thrombosis of Lower Extremity Arteries
 ;;^UTILITY(U,$J,358.3,18620,1,4,0)
 ;;=4^I74.3
 ;;^UTILITY(U,$J,358.3,18620,2)
 ;;=^5007802
 ;;^UTILITY(U,$J,358.3,18621,0)
 ;;=I83.019^^84^965^22
 ;;^UTILITY(U,$J,358.3,18621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18621,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer
 ;;^UTILITY(U,$J,358.3,18621,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,18621,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,18622,0)
 ;;=I83.029^^84^965^21
 ;;^UTILITY(U,$J,358.3,18622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18622,1,3,0)
 ;;=3^Varicose Veins Left Lower Extrem w/ Ulcer
 ;;^UTILITY(U,$J,358.3,18622,1,4,0)
 ;;=4^I83.029
 ;;^UTILITY(U,$J,358.3,18622,2)
 ;;=^5007986
 ;;^UTILITY(U,$J,358.3,18623,0)
 ;;=I83.91^^84^965^4
 ;;^UTILITY(U,$J,358.3,18623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18623,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Right Lower Extremity
 ;;^UTILITY(U,$J,358.3,18623,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,18623,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,18624,0)
 ;;=I83.92^^84^965^3
 ;;^UTILITY(U,$J,358.3,18624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18624,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Left Lower Extremity
 ;;^UTILITY(U,$J,358.3,18624,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,18624,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,18625,0)
 ;;=I83.93^^84^965^2
 ;;^UTILITY(U,$J,358.3,18625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18625,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Bilateral Lower Extremities
 ;;^UTILITY(U,$J,358.3,18625,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,18625,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,18626,0)
 ;;=M79.604^^84^965^18
 ;;^UTILITY(U,$J,358.3,18626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18626,1,3,0)
 ;;=3^Right Limb Pain
 ;;^UTILITY(U,$J,358.3,18626,1,4,0)
 ;;=4^M79.604
 ;;^UTILITY(U,$J,358.3,18626,2)
 ;;=^5013328
 ;;^UTILITY(U,$J,358.3,18627,0)
 ;;=M79.605^^84^965^12
 ;;^UTILITY(U,$J,358.3,18627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18627,1,3,0)
 ;;=3^Left Limb Pain
 ;;^UTILITY(U,$J,358.3,18627,1,4,0)
 ;;=4^M79.605
 ;;^UTILITY(U,$J,358.3,18627,2)
 ;;=^5013329
 ;;^UTILITY(U,$J,358.3,18628,0)
 ;;=Z13.6^^84^965^19
 ;;^UTILITY(U,$J,358.3,18628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18628,1,3,0)
 ;;=3^Screening for Cardiovascular Disorders
 ;;^UTILITY(U,$J,358.3,18628,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,18628,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,18629,0)
 ;;=B48.8^^84^966^62
 ;;^UTILITY(U,$J,358.3,18629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18629,1,3,0)
 ;;=3^Mycoses NEC
 ;;^UTILITY(U,$J,358.3,18629,1,4,0)
 ;;=4^B48.8
 ;;^UTILITY(U,$J,358.3,18629,2)
 ;;=^5000689
 ;;^UTILITY(U,$J,358.3,18630,0)
 ;;=C49.9^^84^966^60
 ;;^UTILITY(U,$J,358.3,18630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18630,1,3,0)
 ;;=3^Malig Neop of Connective/Soft Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,18630,1,4,0)
 ;;=4^C49.9
 ;;^UTILITY(U,$J,358.3,18630,2)
 ;;=^5001136
 ;;^UTILITY(U,$J,358.3,18631,0)
 ;;=C85.80^^84^966^66
 ;;^UTILITY(U,$J,358.3,18631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18631,1,3,0)
 ;;=3^Non-Hodgkin Lymphoma,Unspec Site NEC
 ;;^UTILITY(U,$J,358.3,18631,1,4,0)
 ;;=4^C85.80
 ;;^UTILITY(U,$J,358.3,18631,2)
 ;;=^5001721
 ;;^UTILITY(U,$J,358.3,18632,0)
 ;;=C85.89^^84^966^65
 ;;^UTILITY(U,$J,358.3,18632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18632,1,3,0)
 ;;=3^Non-Hodgkin Lymphoma of Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,18632,1,4,0)
 ;;=4^C85.89
 ;;^UTILITY(U,$J,358.3,18632,2)
 ;;=^5001730
 ;;^UTILITY(U,$J,358.3,18633,0)
 ;;=E11.9^^84^966^22
 ;;^UTILITY(U,$J,358.3,18633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18633,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,18633,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,18633,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,18634,0)
 ;;=E10.9^^84^966^21
 ;;^UTILITY(U,$J,358.3,18634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18634,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,18634,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,18634,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,18635,0)
 ;;=D50.0^^84^966^57
 ;;^UTILITY(U,$J,358.3,18635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18635,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,18635,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,18635,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,18636,0)
 ;;=D50.9^^84^966^58
 ;;^UTILITY(U,$J,358.3,18636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18636,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,18636,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,18636,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,18637,0)
 ;;=D62.^^84^966^3
 ;;^UTILITY(U,$J,358.3,18637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18637,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,18637,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,18637,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,18638,0)
 ;;=D64.9^^84^966^6
 ;;^UTILITY(U,$J,358.3,18638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18638,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,18638,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,18638,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,18639,0)
 ;;=F03.90^^84^966^20
 ;;^UTILITY(U,$J,358.3,18639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18639,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
